Zu "1032900-25-6" wurden 4 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Ceritinib
Artikelnummer: TGM-T1791-100mg
Description: Ceritinib (LDK378) is an ALK tyrosine kinase inhibitor (IC50=200 pM) with selective, ATP-competitive, and oral activity. Ceritinib also inhibits IGF-1R, InsR, and STK22D (IC50=8/7/23 nM). Ceritinib has antitumor activity. Target: IGF-1R, Serine Protease, ALK. Smiles:...
| Schlagworte: | LDK378 |
| Anwendung: | Targets anaplastic lymphoma kinase [EC:2.7.10.1] (ALK, CD246) |
| CAS | 1032900-25-6 |
| MW: | 558.14 D |
ab 45,00 €
Ceritinib
Artikelnummer: Cay19374-1
Ceritinib is an inhibitor of anaplastic lymphoma kinase (ALK, IC50 = 0.2 nM). It is selective for ALK over IGF-1R, InsR, STK22D, and FLT3 (IC50s = 8, 7, 23, and 60 nM, respectively) as well as a panel of 25 additional kinases (IC50s = >0.26 µM for all). Ceritinib inhibits the proliferation of Ba/F3 cells expressing...
| Schlagworte: | LDK 378,... |
| Anwendung: | ALK inhibitor |
| CAS | 1032900-25-6 |
| MW: | 558.1 D |
ab 40,00 €
LDK378
Artikelnummer: LKT-L1340.1
LDK378 is a selective inhibitor of ALK1, a target found in metastatic non-small cell lung cancer (NSCLC).
| Schlagworte: | LDK-378, 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine |
| Anwendung: | ALK1 inhibitor |
| CAS | 1032900-25-6 |
| MW: | 558.13 D |
ab 83,00 €
LDK378
Artikelnummer: SYN-1199-M001
Soluble in DMSO (heat) or ethanol. LDK378 is potent inhibitor against ALK with IC(50) of 0.2nM, shows 40- and 35-fold selectivity against IGF-1R and InsR, respectively. Target: ALK , Kinase Group: RTK , Substrate: Tyrosine
| Schlagworte: | LDK-378 |
| Anwendung: | ALK inhibitor |
| CAS | 1032900-25-6 |
| MW: | 558,1 D |
ab 92,00 €
